Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib: Results of oral provocation tests in patients with NSAID hypersensitivity

Acta Dermato-Venereologica

Volumn 83, Issue 3, 2003, Pages 183-185

  Kruse, Roland ^a   Ruzicka, Thomas ^a   Grewe, Markus ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Drug intolerance; Non steroidal anti inflammatory drugs (NSAIDs); Skin reaction

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOPROPAZON; PIROXICAM; PYRAZOLONE; ROFECOXIB; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG SELECTIVITY; DRUG TOLERANCE; DYSPNEA; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; PRIORITY JOURNAL; PROVOCATION TEST; SHOCK; SIDE EFFECT; TACHYCARDIA; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; LACTONES; PYRAZOLES; SULFONAMIDES; SULFONES;

EID: 0037902147     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310007175     Document Type: Article

References (10)

1. Berges-Gimeno MP, Camacho-Garrido E, Garcia-Rodriguez RM, Alfaya T, Martin Garcia C, Hinojosa M. Rofecoxib safe in NSAID hypersensitivity. Allergy 2001; 56: 1017-1018.
2. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001; 108: 47-51.
3. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001; 31: 219-225.
4. Zollner TM, Ahlbach S, Kaufmann R, Boehnke WH. Verträglichkeit des selektiven Cyclooxygenase-2-Inhibitors Rofecoxib bei Intoleranz gegenüber nicht-steroidalen Antiphlogistika. Dtsch Med Wschr 2001; 126: 386-388.
5. Asero R. Tolerability of rofecoxib. Allergy 2001; 56: 916-917.
6. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001; 87: 201-204.
7. Grob M, Scheidegger P, Wüthrich B. Allergic skin reaction to celecoxib. Dermatology 2000; 201: 383.
8. Levy MB, Fink JN. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001; 87: 72-73.
9. Schellenberg RR, Isserow SH. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor. N Engl J Med 2001; 345: 1856.
10. Yoshida S, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Amayasu H. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol 2000; 106: 1201-1202.